MAHINDRA MANULIFE ASIA PACIFIC REITs FOF
An open ended fund of fund scheme investing in Manulife Global Fund – Asia Pacific REIT Fund

Data as on 31st, December 2023

Investment Objective The investment objective of the Scheme is to provide long term capital appreciation by investing predominantly in units of Manulife Global Fund – Asia Pacific REIT Fund, an overseas fund primarily investing in real estate investment trusts (REITs) in the Asia Pacific ex-Japan region. However, there can be no assurance that the investment objective of the Scheme will be achieved
Fund Features • Aims to achieve capital appreciation
• Aims to provide Inflation Hedge
• Diversification in real estate with very low investment
Fund Manager and Experience Fund Manager: Mr. Kush Sonigara^##
Total Experience: 12 years (^Dedicated Fund Manager for Overseas Investments)
Experience in managing this fund: 6 months (Managing since November 01, 2022)
Fund Manager (Debt): Mr. Amit Garg
Total Experience: 19 years
Experience in managing this fund: 2 Years and 2 month (Managing since October 20, 2021)
Date of allotment: October 20, 2021
Benchmark: FTSE EPRA Nareit Asia ex Japan REITs Index
Options: IDCW (IDCW Option will have IDCW Reinvestment (D) & IDCW Payout facility) and Growth (D) D-Default
Minimum Application Amount: Rs. 5,000 and in multiples of Rs. 1/- thereafter
Minimum Additional Purchase Amount: Rs. 1,000 and in multiples of Rs. 1/- thereafter
Minimum SIP Amount: Rs. 1000 (Weekly & Monthly) and Rs. 1500 (Quarterly SIP) and in multiples of Rs. 1 thereafter
Monthly AAUM as on December 31, 2023 (Rs.in Cr.): 25.93
Quarterly AAUM as on December 31, 2023 (Rs.in Cr.): 24.72
Monthly AUM as on December 31, 2023 (Rs. in Cr.): 26.84
Total Expense Ratio1 as on December 31, 2023: Regular Plan: 1.37%
Direct Plan: 0.42%
1Includes additional expenses charged in terms of Regulation 52 (6A) (b) and 52 (6A) (c) of SEBI (Mutual Funds) Regulations, 1996 and Goods and Service Tax.
Load Structure: Entry Load: N.A.
Exit Load: 10% of the units allotted shall be redeemed without any exit load, on or before completion of 24 months from the date of allotment of Units.
Any redemption in excess of the above limit shall be subject to the following exit load:
• An exit load of 1% is payable if Units are redeemed / switched-out on or before completion of 12 months from the date of allotment of Units;
• Nil - If Units are redeemed / switched-out after completion of 12 months from the date of allotment of Units.
Note: Pursuant to change in Fund Management Responsibilities, the scheme shall be managed by Mr. Pranav Patel (Dedicated Fund Manager for Overseas Investment) and Amit Garg effective January 5, 2024. 

Mahindra Manulife Asia Pacific REIT FoF
CAGR Returns (%)
Value of Investment of Rs. 10,000*
NAV / Index Value
(as on December 29, 2023)
Managed by Mr. Kush Sonigara$## & Mr. Amit Garg
1 Year
Since Inception
1 Year
Since Inception
Regular Plan - Growth Option
0.51
-5.02
10,051
8,932
8.9318
Direct Plan - Growth Option
1.49
-4.06
10,149
9,132
9.1322
FTSE EPRA Nareit Asia ex Japan REITs Index^
2.98
0.45
10,297
10,099
267,739.22
Nifty 50 TRI^^
21.36
9.52
12,130
12,204
31,933.93

^Benchmark ^^Additional Benchmark. Inception/Allotment date: 20-Oct-21. CAGR – Compounded Annual Growth Rate. Past performance may or may not be sustained in future and should not be used as a basis of comparison with other investments. Since inception returns of the scheme is calculated on face value of Rs. 10 invested at inception. The performance details provided above are of Growth Option under Regular and Direct Plan. Different Plans i.e Regular Plan and Direct Plan under the scheme has different expense structure. *Based on standard investment of Rs. 10,000 made at the beginning of the relevant period. Mr. Kush Sonigara is managing this fund since July 03, 2023 For performance details of other schemes managed by the Fund Manager(s), please click here | Best Viewed in Landscape mode
Note: $
Dedicated Fund Manager for Overseas Investments
Note:
Pursuant to change in Fund Management Responsibilities, the scheme shall be managed by Mr. Pranav Patel (Dedicated Fund Manager for Overseas Investment) and Amit Garg effective January 5, 2024. 

Mahindra Manulife Asia Pacific REITs FOF
Regular Plan
Direct Plan
FTSE EPRA Nareit Asia ex
Japan REITs Index^
Nifty 50 Index TRI^^
SIP Investment Period
Total Amount Invested
()
Market Value
()
CAGR Returns (%)
Market Value
()
CAGR Returns (%)
Market Value
()
CAGR Returns (%)
Market Value
()
CAGR Returns (%)
1 Year
120,000
125,522
8.74
126,145
9.74
126,572
10.43
140,493
33.52
Since Inception
270,000
272,842
0.91
275,882
1.88
281,324
3.59
331,856
18.89

^Benchmark ^^Additional Benchmark. CAGR – Compounded Annual Growth Rate. Inception/Allotment date: 24-Aug-20. Past performance may or may not be sustained in future and should not be used as a basis of comparison with other investments. Returns greater than 1 year period are compounded annualized. For SIP returns, monthly investment of equal amounts invested on the 1st business day of every month has been considered. CAGR Returns (%) are computed after accounting for the cash flow by using the XIRR method (investment internal rate of return). For SIP Performance please click here | Best Viewed in Landscape mode

NAV as on December 29, 2023
NAV/Unit
Regular Plan (In Rs.)
Direct Plan (In Rs.)
IDCW
8.9318
9.1322
Growth
8.9318
9.1322
IDCW: Income Distribution cum Capital Withdrawal

Company / Issuer
% of Net Assets
International Mutual Fund Units
98.63%
Manulife Global Fund SICAV-Asia Pacific REIT
98.63%
Cash & Other Receivables
1.37%
Grand Total
100.00%
as on December 31, 2023

MAHINDRA MANULIFE MULTI CAP BADHAT YOJANA

Product Suitability
This Product is Suitable for investors who are seeking*
  • Capital appreciation over long term
  • Investments in units of Manulife Global Fund – Asia Pacific REIT Fund
Scheme Riskometers
Benchmark Riskometers

MAHINDRA MANULIFE MULTI CAP BADHAT YOJANA

MAHINDRA MANULIFE MULTI CAP BADHAT YOJANA
Scheme Benchmark: FTSE EPRA Nareit Asia ex Japan REITs Index
* Investors should consult their financial advisers if in doubt about whether the product is suitable for them.